Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs VanEck Semiconductor ETF (SMH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs VanEck Semiconductor ETF — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.97 (market cap $31.07B), while VanEck Semiconductor ETF trades at $554.22 (market cap $71.21B). The key difference: VanEck Semiconductor ETF is far larger — about 2.3× GE HealthCare Technologies Inc. Common Stock's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while VanEck Semiconductor ETF pays none. Which is the better fit depends on your goals.
| GEHC | SMH | |
|---|---|---|
Market Cap | $31.07B | $71.21B |
Volume | 3,443,020 | 7,965,961 |
Sector | Health | — |
52-Week High | $88.16 | $668.91 |
52-Week Low | $59.48 | $325.10 |
Enterprise Value | $39.53B | — |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 102 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
SMH, the VanEck Semiconductor ETF, trades at $564.74, down 4.44% over 24 hours amid sector volatility. Technical indicators show a mixed picture with a bullish overall signal but bearish moving averages, while RSI_6 at 26.18 suggests potential oversold conditions. Recent news highlights strong 2026 performance, with the ETF up around 69% year-to-date, outpacing major holdings like Nvidia, and benefiting from AI-driven semiconductor demand and industry consolidation such as AMD's acquisition of World Labs.
The outlook for SMH remains positive due to robust sector growth and AI expansion, though risks include high concentration in top holdings and sensitivity to tech sector swings. Investors should weigh the ETF's historical outperformance against potential volatility from trade tensions and macroeconomic factors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About VanEck Semiconductor ETF
The fund normally invests at least 80% of its total assets in securities that comprise the target index. The index includes common stocks and depositary receipts of US exchange-listed companies in the semiconductor industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a US exchange. The fund is non-diversified.
Read more on SMH →
